The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug Discovery Technologies-Global Market Insights and Sales Trends 2025
Synopsis
This report mainly focuses on drug discovery technologies marekt. Current drug discovery technologies aims to discover all the modern techniques and technologies used in drug discovery.
The global Drug Discovery Technologies market size is expected to reach US$ 76370 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Discovery Technologies in various end use industries. The expanding demands from the Pharmaceutical Companies, Research Institutes and Others,, are propelling Drug Discovery Technologies market. Small-molecule Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biologics segment is estimated at % CAGR for the next seven-year period.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Discovery Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Discovery Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Discovery Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Discovery Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Discovery Technologies covered in this report include Agilent, GE Healthcare, Albany Molecular Research Inc., Affymetrix, Bayer Healthcare, Novartis and AstraZeneca, etc.
The global Drug Discovery Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Global Drug Discovery Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Discovery Technologies market, Segment by Type:
Small-molecule Drugs
Biologics
Global Drug Discovery Technologies market, by Application
Pharmaceutical Companies
Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Discovery Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
This report mainly focuses on drug discovery technologies marekt. Current drug discovery technologies aims to discover all the modern techniques and technologies used in drug discovery.
The global Drug Discovery Technologies market size is expected to reach US$ 76370 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Discovery Technologies in various end use industries. The expanding demands from the Pharmaceutical Companies, Research Institutes and Others,, are propelling Drug Discovery Technologies market. Small-molecule Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biologics segment is estimated at % CAGR for the next seven-year period.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Discovery Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Discovery Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Discovery Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Discovery Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Discovery Technologies covered in this report include Agilent, GE Healthcare, Albany Molecular Research Inc., Affymetrix, Bayer Healthcare, Novartis and AstraZeneca, etc.
The global Drug Discovery Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Global Drug Discovery Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Discovery Technologies market, Segment by Type:
Small-molecule Drugs
Biologics
Global Drug Discovery Technologies market, by Application
Pharmaceutical Companies
Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Discovery Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Drug Discovery Technologies
1.1 Drug Discovery Technologies Market Overview
1.1.1 Drug Discovery Technologies Product Scope
1.1.2 Drug Discovery Technologies Market Status and Outlook
1.2 Global Drug Discovery Technologies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug Discovery Technologies Market Size by Region (2018-2029)
1.4 Global Drug Discovery Technologies Historic Market Size by Region (2018-2023)
1.5 Global Drug Discovery Technologies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug Discovery Technologies Market Size (2018-2029)
1.6.1 North America Drug Discovery Technologies Market Size (2018-2029)
1.6.2 Europe Drug Discovery Technologies Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Discovery Technologies Market Size (2018-2029)
1.6.4 Latin America Drug Discovery Technologies Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Discovery Technologies Market Size (2018-2029)
2 Drug Discovery Technologies Market by Type
2.1 Introduction
2.1.1 Small-molecule Drugs
2.1.2 Biologics
2.2 Global Drug Discovery Technologies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug Discovery Technologies Historic Market Size by Type (2018-2023)
2.2.2 Global Drug Discovery Technologies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug Discovery Technologies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug Discovery Technologies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug Discovery Technologies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug Discovery Technologies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug Discovery Technologies Revenue Breakdown by Type (2018-2029)
3 Drug Discovery Technologies Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Companies
3.1.2 Research Institutes
3.1.3 Others
3.2 Global Drug Discovery Technologies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug Discovery Technologies Historic Market Size by Application (2018-2023)
3.2.2 Global Drug Discovery Technologies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug Discovery Technologies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug Discovery Technologies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug Discovery Technologies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug Discovery Technologies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug Discovery Technologies Revenue Breakdown by Application (2018-2029)
4 Drug Discovery Technologies Competition Analysis by Players
4.1 Global Drug Discovery Technologies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Discovery Technologies as of 2022)
4.3 Date of Key Players Enter into Drug Discovery Technologies Market
4.4 Global Top Players Drug Discovery Technologies Headquarters and Area Served
4.5 Key Players Drug Discovery Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Discovery Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent
5.1.1 Agilent Profile
5.1.2 Agilent Main Business
5.1.3 Agilent Drug Discovery Technologies Products, Services and Solutions
5.1.4 Agilent Drug Discovery Technologies Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Drug Discovery Technologies Products, Services and Solutions
5.2.4 GE Healthcare Drug Discovery Technologies Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Albany Molecular Research Inc.
5.3.1 Albany Molecular Research Inc. Profile
5.3.2 Albany Molecular Research Inc. Main Business
5.3.3 Albany Molecular Research Inc. Drug Discovery Technologies Products, Services and Solutions
5.3.4 Albany Molecular Research Inc. Drug Discovery Technologies Revenue (US$ Million) & (2018-2023)
5.3.5 Affymetrix Recent Developments
5.4 Affymetrix
5.4.1 Affymetrix Profile
5.4.2 Affymetrix Main Business
5.4.3 Affymetrix Drug Discovery Technologies Products, Services and Solutions
5.4.4 Affymetrix Drug Discovery Technologies Revenue (US$ Million) & (2018-2023)
5.4.5 Affymetrix Recent Developments
5.5 Bayer Healthcare
5.5.1 Bayer Healthcare Profile
5.5.2 Bayer Healthcare Main Business
5.5.3 Bayer Healthcare Drug Discovery Technologies Products, Services and Solutions
5.5.4 Bayer Healthcare Drug Discovery Technologies Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Healthcare Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Drug Discovery Technologies Products, Services and Solutions
5.6.4 Novartis Drug Discovery Technologies Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Drug Discovery Technologies Products, Services and Solutions
5.7.4 AstraZeneca Drug Discovery Technologies Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
6 North America
6.1 North America Drug Discovery Technologies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug Discovery Technologies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Technologies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Discovery Technologies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Technologies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Discovery Technologies Market Dynamics
11.1 Drug Discovery Technologies Industry Trends
11.2 Drug Discovery Technologies Market Drivers
11.3 Drug Discovery Technologies Market Challenges
11.4 Drug Discovery Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
